A detailed history of Capital Group Private Client Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 319,636 shares of NVO stock, worth $31.9 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
319,636
Previous 324,427 1.48%
Holding current value
$31.9 Million
Previous $46.3 Million 17.81%
% of portfolio
0.38%
Previous 0.48%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $570,464 - $696,707
-4,791 Reduced 1.48%
319,636 $38.1 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $1.18 Million - $1.42 Million
-9,650 Reduced 2.89%
324,427 $46.3 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $17.8 Million - $23.7 Million
-174,269 Reduced 34.28%
334,077 $42.9 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $5.67 Million - $6.81 Million
64,594 Added 14.56%
508,346 $52.6 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $20.1 Million - $44.1 Million
220,842 Added 99.07%
443,752 $40.4 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $168,458 - $186,462
1,080 Added 0.49%
222,910 $36.1 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $574,223 - $690,508
4,339 Added 2.0%
221,830 $35.3 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $69,016 - $91,077
673 Added 0.31%
217,491 $29.4 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $992,912 - $1.22 Million
-10,421 Reduced 4.59%
216,818 $21.6 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $3 Million - $3.54 Million
29,024 Added 14.64%
227,239 $25.3 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $89,562 - $108,263
-962 Reduced 0.48%
198,215 $22 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $351,016 - $428,629
-3,661 Reduced 1.8%
199,177 $22.3 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $17.1 Million - $21.6 Million
202,838 New
202,838 $19.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $225B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.